News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
30-Mar-2011 - Protein aggregation, generally associated with Alzheimer’s and mad cows disease, turns out to play a significant role in cancer. In a paper published in Nature Chemical Biology, Frederic Rousseau and Joost Schymkowitz, both from VIB, Vrije Universiteit Brussel and K.U.Leuven describe that certain ...
Cop1 protects against cancer rather than promoting it
17-Mar-2011 - Jean-Christophe Marine (VIB, K.U.Leuven) strongly argues against the use of Cop1-inhibitory drugs. The protein Cop1 has –for a long time - been seen as an attractive drug target for cancer. But Jean-Christophe Marine found out that Cop1 acts as a tumor suppressor, and thus inhibits tumor ...
VIB-K.U.Leuven scientist Max Mazzone receives FFMI grant worth € 350,000
09-Feb-2011 - The Fournier-Majoie Foundation for Innovation (FFMI) has awarded Max Mazzone of VIB-K.U.Leuven a grant for research into a new method of early detection of colon cancer. The technique could also make it possible to better monitor the development of the disease in patients. Mazzone, in close ...
14-Jan-2011 - Scientists attached to VIB and K.U.Leuven have succeeded in decoding a potential new anti-cancer mechanism. The researchers discovered that normalizing abnormal tumor blood vessels through HRG (histidine-rich glycoprotein) prevents metastasis of tumor cells and enhances chemotherapy ...
10-Jan-2011 - Genetic resistance to antibiotics is not the only trick bacteria use to resist eradication– they also have a second defence strategy known as persistence that can kick in. Researchers reporting in the Journal of Medical Microbiology have now demonstrated for the first time that interplay occurs ...
16-Nov-2010 - VIB researchers attached to the K.U.Leuven have improved the fruit fly as a model for studying the connections between brain cells. The researchers developed a specific marker for a part of the fly's nerve cell which had previously been difficult to distinguish. Their discovery will not only ...
22-Sep-2010 - The Katholieke Universiteit Leuven and the European Investment Fund (EIF) are investing an additional 16 million euro in the Centre for Drug Design and Discovery (CD3), thereby increasing the total capital of CD3 to 24 million euro. CD3 allows fundamental innovative biomedical research carried ...
16-Sep-2010 - Katholieke Universiteit Leuven (K.U.Leuven, Belgium) announced that on July 29th, 2010 they entered into a license agreement with Pfizer. The license agreement grants Pfizer exclusive and sublicenseable worldwide rights to further develop and commercialise K.U.Leuven’s compounds with a new ...
20-Aug-2010 - A new, fast way to analyse DNA could be used to sequence the genomes of viruses and in the future help tackle genetic disorders such as schizophrenia and congenital heart defects. Robert Neely and colleagues have used a DNA methyltransferase enzyme to label the 5’-GCGC-3’ DNA sequences with a ...
05-Jul-2010 - Oxford BioMedica, VIB and the UK Motor Neurone Disease Association (MND Association) announced the award by MND Association of a research grant to support the further preclinical evaluation of MoNuDin® for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease). The grant is ...
© 1997-2024 LUMITOS AG, All rights reserved